Design and preparation of non-tagged Yersinia pestis LcrV antigen in Escherichia coli and its immunogenicity in BALB/c mice

Protein Expression and Purification

Volumn 57, Issue 2, 2008, Pages 136-142

  li, Jianmin ^a   Li, Bing ^a   Li, Guanlin ^a   Ren, Jun ^a   Zhang, Jinlong ^a   Xu, Chun'e ^a   Yang, Xiuxu ^a   Liu, Shuling ^a   Fu, Ling ^a   Chen, Wei ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Expression; Immunogenicity; LcrV; Purification

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; LCRV PROTEIN, YERSINIA; PORE FORMING CYTOTOXIC PROTEIN; PROTEIN SUBUNIT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE VECTOR; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; SEQUENCE ANALYSIS; WESTERN BLOTTING; YERSINIA PESTIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENETIC VECTORS; MICE; MICE, INBRED BALB C; PORE FORMING CYTOTOXIC PROTEINS; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, PROTEIN; YERSINIA PESTIS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; YERSINIA PESTIS;

EID: 37349038233     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.10.011     Document Type: Article

References (44)

1. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., and Titball R.W. A comparison of plague vaccine USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13 (1995) 1551-1556
2. Robinson V.L., Oyston P.C., and Titball R.W. A dam mutant of Yersinia pestis is attenuated and induces protection against plague. FEMS Microbiol. Lett. 15 (2005) 251-256
3. Taylor V.L., Titball R.W., and Oyston P.C. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 151 (2005) 1919-1926
4. Reddin K.M., Easterbrook T.J., Robinson A., Williamson D., and Rhind-tutt R. Large-scale purification of the F1 antigen of Yersinia pestis. Contri. Microbiol. Immunol. 13 (1995) 329-330
5. Simpson W.J., Thomas R.E., and Schwan T.G. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am. J. Trop. Med. Hyg. 43 (1990) 389-396
6. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., and Titball R.W. Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63 (1995) 2854-2858
7. Anderson Jr. G.W., Leary S.E., Williamson E.D., Titball R.W., Welkos S.L., Worsham P.L., and Friedlander A.M. Recombinant V antigen protects mice against pneumonic and bubonic plague against F1 positive and negative strains of Yersinia pestis. Infect. Immun. 63 (1995) 2854-2858
8. Diane Williamson E., Eley S.M., Griffin K.F., Green M., Russell P., Leary S.E.C., Oyston P.C.F., Easterbrook T., Reddin K.M., Robinson A., and Richard W. Titball. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12 (1995) 223-230
9. Andrews G.P., Heath D.G., Anderson Jr. G.W., Welkos S.L., and Friedlander A.M. Fraction 1 capsular Antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 64 (1996) 2180-2187
10. Hill J., GriBin K.F., and GriBin K.F. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect. Immun. 65 (1997) 4476-4482
11. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15 (1997) 1079-1084
12. Reddin K.M., Easterbrook T.J., Eley S.M., Russell P., Mobsby V.A., Jones D.H., Farrar G.H., Williamson E.D., and Robinson A. Comparison of the immunological and protective responses elicited by micro-encapsulated formulations of the F1 antigen from Yersinia pestis. Vaccine 16 (1998) 761-767
13. Miller J., Williamson E.D., Lakey J.H., Pearce M.J., Jones S.M., and Titball R.W. Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity. FEMS Immunol. Med. Microbiol. 21 (1998) 213-221
14. Anderson Jr. G.W., Heath D.G., Bolt C.R., Welkos S.L., and Friedlander A.M. Short- and long-term efficiency of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58 (1998) 793-799
15. Benner G.E., Andrews G.P., Russell Byrne W., Strachan S.D., Sample A.K., Heath D.G., and Friedlander A.M. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect. Immun. 67 (1999) 1922-1928
16. Williamson E.D., Vesey P.M., Gillhespy K.J., et al. IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116 (1999) 107-114
17. Eyles J.E., Williamson E.D., Spiers I.D., Stagg A.J., Jones S.M., and Alpar H.O. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. J. Control. Release 63 (2000) 191-200
18. Eyles J.E., Williamson E.D., Spiers I.D., et al. Protection studies following bronchopulmonary and intramuscular immunisation with Yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy. Vaccine 18 (2000) 3266-3271
19. Jones S.M., Day F., Stagg A.J., et al. Protection conferred by a fully recombinant subunit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 19 (2000) 358-366
20. Elvin S.J., and William-son E.D. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses. Microb. Pathog. 29 (2000) 223-230
21. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A single dose sub-unit vaccine protects against pneumonic plague. Vaccine 19 (2000) 566-571
22. Carr S., Miller J., Leary S.E.C., Bennett A.M., Ho A., and Williamson E.D. Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems. Vaccine 18 (2000) 153-159
23. Griffin K.F., Eyles J.E., Spiers I.D., Alpar H.O., and Williamson E.D. Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN- or IL-4, but not IL-6. Vaccine 20 (2002) 3650-3657
24. Jones1 S.M., Griffin K.F., Hodgson I., and Williamson E.D. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 21 (2003) 3912-3918
25. Eyles J.E., Elvin S.J., Westwood A., Lebutt C.S., Alpar H.O., Somavarapu S., and Williamson E.D. Immunization against plague by transcutaneous and intradermal application of subunit antigens. Vaccine. 22 (2004) 4365-4373
26. Griffin K., Bedford R., Townson K., et al. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine. FEMS Immunol. Med. Microbiol. 43 (2005) 425-430
27. Chalton D.A., Musson J.A., Flick-Smith H., Walker N., McGregor A., Lamb H.K., Williamson E.D., Miller J., Robinson J.H., and Lakey J.H. Immunogenicity of a Yersinia pestis vaccine antigen monomerised by circular permutation. Infect. Immun. 74 (2006) 6624-6631
28. Elvin S.J., Eyles J.E., Howard K.A., Ravichandran E., Somavarappu S., Alpar H.O., and Williamson E.D. Protection against bubonic and pneumonic plague with a single dose micro-encapsulated sub-unit vaccine. Vaccine 24 (2006) 4433-4439
29. Heath D.G., Anderson Jr. G.W., Mauro J.M., et al. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16 (1998) 1131-1137
30. Rocke T.E., Mencher J., Smith S.R., Friedlander A.M., Andrews G.P., and Baeten L.A. Recombinant F1-V fusion protein protects black-footed ferrets (Mustela nigripes) against virulent Yersinia pestis infection. J. Zoo. Wildl. Med. 35 (2004) 142-146
31. Powell B.S., Andrews G.P., Enama J.T., Jendrek S., Bolt C., Worsham P., Pullen J.K., Ribot W., Hines H., Smith L., Heath D.G., and Adamovicz J.J. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol. Prog. 21 (2005) 1490-1510
32. Glynn A., Freytag L.C., and Clements J.D. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine 23 (2005) 1957-1965
33. Glynn A., Roy C.J., Powell B.S., Adamovicz J.J., Freytag L.C., and Clements J.D. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infect. Immun. 73 (2005) 5256-5261
34. Williamson E.D., Bennett A.M., Perkins S.D., Beedham R.J., Miller J., and Baillie L.W.J. Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague. Vaccine 20 (2002) 2933-2941
35. Grosfeld H., Bino T., Flashner Y., Ber R., Mamroud E., Lustig S., Velan B., Shafferman A., and Cohen S. Vaccination with plasmid DNA expressing the Yersinia pestis capsular protein F1 protects mice against plague. Adv. Exp. Med. Biol. 529 (2003) 423-424
36. Grosfeld H., Cohen S., Bino T., Flashner Y., Ber R., Mamroud E., Kronman C., Shafferman A., and Velan B. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infect. Immun. 71 (2003) 374-383
37. Sabhnani L., and Rao D.N. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol. Med. Microbiol. 27 (2000) 155-162
38. Sabhnani L., Manocha M., Sridevi K., Shashikiran D., Rayanade R., and Rao D.N. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles. FEMS Immunol. Med. Microbiol. 38 (2003) 215-229
39. Titball R.W., Howells A.M., Oyston P.C., and Williamson E.D. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague. Infect. Immun. 65 (1997) 1926-1930
40. Morton M., Garmory H.S., Perkins S.D., O'Dowd A.M., Griffin K.F., Turner A.K., Bennett A.M., and Titball R.W. A Salmonella enterica serovar typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice. Vaccine 22 (2004) 2524-2532
41. Calhoun L.N., and Kwon Y.M. Salmonella-based plague vaccines for bioterrorism. J. Microbiol. Immunol. Infect. 39 (2006) 92-97
42. Palin A., Chattopadhyay A., Park S., Delmas G., Suresh R., Senina S., Perlin D.S., and Rose J.K. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine (2006)
43. Chiuchiolo M.J., Boyer J.L., Krause A., Senina S., Hackett N.R., and Crystal R.G. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. J. Infect. Dis. 194 (2006) 1249-1257
44. Titball R.W., and Williamson E.D. Yersinia pestis (plague) vaccines. Expert. Opin. Biol. Ther. 4 (2004) 965-973